News

New trial results for anti-migraine drugs could revolutionize migraine treatment

A recent article from Neurology Today brings some potentially life changing news to those who suffer from migraines. Four pharmaceutical companies are racing to develop a potentially game changing treatment for those who suffer from migraines, and the trial results look promising. The anti-migraine drugs target CGRP or calcintonin gene related peptide.

Read the full article here